Douglas CE - Search Results

1

Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective.

Cummings KM, Brown A, Douglas CE. Cummings KM, et al. Among authors: douglas ce. Tob Control. 2006 Dec;15 Suppl 4(Suppl 4):iv84-9. doi: 10.1136/tc.2004.009837. Tob Control. 2006. PMID: 17130628 Free PMC article. Review.

2

Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.

Milberger S, Davis RM, Douglas CE, Beasley JK, Burns D, Houston T, Shopland D. Milberger S, et al. Among authors: douglas ce. Tob Control. 2006 Dec;15 Suppl 4(Suppl 4):iv17-26. doi: 10.1136/tc.2006.016956. Tob Control. 2006. PMID: 17130620 Free PMC article.

3

The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.

Davis RM, Douglas CE, Beasley JK. Davis RM, et al. Among authors: douglas ce. Tob Control. 2006 Dec;15 Suppl 4(Suppl 4):iv4-8. doi: 10.1136/tc.2006.016667. Tob Control. 2006. PMID: 17130623 Free PMC article. Review.

4

An Analysis of the FTC's Attempt to Stop the Altria-Juul Labs Deal.

Levy DT, Douglas CE, Sanchez-Romero LM, Cummings KM, Sweanor DT. Levy DT, et al. Among authors: douglas ce. Tob Regul Sci. 2020 Jul;6(4):302-305. doi: 10.18001/TRS.6.4.7. Tob Regul Sci. 2020. PMID: 32901222 Free PMC article.

5

The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.

Cadham CJ, Knoll M, Sánchez-Romero LM, Cummings KM, Douglas CE, Liber A, Mendez D, Meza R, Mistry R, Sertkaya A, Travis N, Levy DT. Cadham CJ, et al. Among authors: douglas ce. Med Decis Making. 2022 Jul;42(5):684-703. doi: 10.1177/0272989X211053794. Epub 2021 Oct 25. Med Decis Making. 2022. PMID: 34694168 Free PMC article.

6

United States public health officials need to correct e-cigarette health misinformation.

Pesko MF, Cummings KM, Douglas CE, Foulds J, Miller T, Rigotti NA, Warner KE. Pesko MF, et al. Among authors: douglas ce. Addiction. 2023 May;118(5):785-788. doi: 10.1111/add.16097. Epub 2022 Dec 12. Addiction. 2023. PMID: 36507802 No abstract available.

7

Do Tobacco Companies Have an Incentive to Promote "Harm Reduction" Products?: The Role of Competition.

Levy DT, Thirlway F, Sweanor D, Liber A, Maria Sanchez-Romero L, Meza R, Douglas CE, Michael Cummings K. Levy DT, et al. Among authors: douglas ce. Nicotine Tob Res. 2023 Nov 22;25(12):1810-1821. doi: 10.1093/ntr/ntad014. Nicotine Tob Res. 2023. PMID: 36692328 Free PMC article.

8

Taking aim at the bull's-eye: the nicotine in tobacco products.

Douglas CE. Douglas CE. Tob Control. 1998 Autumn;7(3):215-8. doi: 10.1136/tc.7.3.215. Tob Control. 1998. PMID: 9825406 Free PMC article. Review. No abstract available.

9

Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.

Douglas CE, Davis RM, Beasley JK. Douglas CE, et al. Tob Control. 2006 Dec;15 Suppl 4(Suppl 4):iv9-16. doi: 10.1136/tc.2006.016725. Tob Control. 2006. PMID: 17130629 Free PMC article.

10

Follow the money: a closer look at US tobacco industry marketing expenditures.

Levy DT, Liber AC, Cadham C, Sanchez-Romero LM, Hyland A, Cummings M, Douglas C, Meza R, Henriksen L. Levy DT, et al. Tob Control. 2023 Sep;32(5):575-582. doi: 10.1136/tobaccocontrol-2021-056971. Epub 2022 Jan 24. Tob Control. 2023. PMID: 35074930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters